---
title: "Cathie Wood is buying this up-and-coming biotech stock. Should you follow her lead?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293245844.md"
description: "Beam Therapeutics' growing pipeline could reward patient investors."
datetime: "2026-07-20T18:43:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293245844.md)
  - [en](https://longbridge.com/en/news/293245844.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293245844.md)
generator: "portal-rs"
---

# Cathie Wood is buying this up-and-coming biotech stock. Should you follow her lead?

Beam Therapeutics' growing pipeline could reward patient investors.

### Related Stocks

- [BEAM.US](https://longbridge.com/en/quote/BEAM.US.md)

## Related News & Research

- [Beam Therapeutics names Eric Foster chief commercial officer](https://longbridge.com/en/news/297640952.md)
- [Beam Therapeutics (NASDAQ:BEAM) Stock Price Up 5.8%  - What's Next?](https://longbridge.com/en/news/296937626.md)
- [Dyadic International (Nasdaq: DYAI) Advances Next-Generation Biomanufacturing with Global Health Support](https://longbridge.com/en/news/297564670.md)
- [C4 Therapeutics to present Phase 1 biomarker data on cemsidomide plus dexamethasone in multiple myeloma trial at IMS meeting](https://longbridge.com/en/news/297902451.md)
- [11:00 ETCovationBio's Xatryx® Mass Production On Spec, to Debut First Non‑Food Bio‑Based Athletic Insole at NW Materials Show in the U.S.](https://longbridge.com/en/news/297804526.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**